References
- 1World Health Organization. Major NCDs and their risk factors. Published April 7, 2016. Accessed September 29, 2020.
https://www.who.int/ncds/introduction/en/ . - 2Dominican Republic. World Health Organization – Noncommunicable Diseases (NCD) Country Profiles, 2018. Published 2018. Accessed February 6, 2020.
https://www.who.int/nmh/countries/dom_en.pdf . - 3World Health Organization. Noncommunicable diseases. Published June 1, 2018. Accessed September 29, 2020.
https://www.who.int/en/news-room/fact-sheets/detail/noncommunicable-diseases . - 4Dominican Republic. Institute for Health Metrics and Evaluation. Published September 18, 2017. Accessed March 19, 2021.
http://www.healthdata.org/dominican-republic . - 5Global Burden of Disease (GBD) 2017 study findings. Institute for Health Metrics and Evaluation. Published April 3, 2019. Accessed September 29, 2020.
http://www.healthdata.org/presentation/global-burden-disease-gbd-2017-study-findings . - 6Castro B, Ing L, Park Y, Abrams J, Ryan M. Addressing noncommunicable disease in Dominican Republic: barriers to hypertension and diabetes care. Ann Glob Health. 2018; 84(4): 625–629. DOI: 10.29024/aogh.2370
- 7Sykes KJ. Short-term medical service trips: A systematic review of the evidence. Am J Public Health. 2014; 104(7): e38–e48. DOI: 10.2105/AJPH.2014.301983
- 8Martiniuk AL, Manouchehrian M, Negin JA, Zwi AB. Brain gains: A literature review of medical missions to low and middle-income countries. BMC Health Serv Res. 2012; 12: 134. DOI: 10.1186/1472-6963-12-134
- 9Maki J, Qualls M, White B, Kleefield S, Crone R. Health impact assessment and short-term medical missions: A methods study to evaluate quality of care. BMC Health Serv Res. 2008; 8: 121. DOI: 10.1186/1472-6963-8-121
- 10Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: The NHANES I follow-up study cohort. Lancet. 2008; 371(9616): 923–931. DOI: 10.1016/S0140-6736(08)60418-3
- 11Aspirin for the prevention of cardiovascular disease: Preventive medication. United States Preventive Services Task Force. Published March 15, 2009. Accessed November 30, 2021.
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication . - 12Statin use for the primary prevention of cardiovascular disease in adults: Preventive medication. United States Preventive Services Task Force. Published November 13, 2016. Accessed November 30, 2021.
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication . - 13Hochheimer C, Khalid M, Vy M, Chang G, Tu D, Ryan M. Addressing noncommunicable disease on short-term medical trips: A longitudinal study of hypertension treatment in Santo Domingo. Ann Glob Health. 2017; 83(3–4): 471–477. DOI: 10.1016/j.aogh.2017.10.004
- 14Pinto E. Blood pressure and ageing. Postgrad Med J. 2007; 83(976): 109–114. DOI: 10.1136/pgmj.2006.048371
- 15Morales D, Clay W, Khamishon R, et al. Bridging the gap: Including patient voices in short-term medical mission evaluations. Ann Glob Health. 2019; 85(1): 86. DOI: 10.5334/aogh.2431